Most Read Articles
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
Pearl Toh, Yesterday
Getting just under one extra hour of sleep per night can go a long way for the health of college students, who are often sleep-deprived, a study suggests.
29 Nov 2019
Saxagliptin 5 mg, dapagliflozin 10 mg FC tab
Roshini Claire Anthony, 5 days ago

The CA125* test could be useful at detecting ovarian cancer and various other cancers in the primary care setting, particularly for women aged >50 years, according to a study presented at the recent NCRI** Cancer Conference held in Glasgow, Scotland, UK.

Clinical pharmacist specialists may aid in drug therapy management of HCV-infected patients

5 days ago
Clinical pharmacists ought to receive their well-deserved specialist status, and be recognised as an asset to the healthcare team.

Utilizing a clinical pharmacist specialist in a hepatitis C virus (HCV) treatment clinic may help improve drug therapy management of HCV-infected patients treated with direct-acting antivirals (DAAs), suggests a recent study.

A total of 132 patients were managed by a clinical pharmacist specialist. Of these, 87 (66 percent) were treated with ledipasvir/sofosbuvir, 29 (22 percent) with paritaprevir/ritonavir/ombitasvir plus dasabuvir, and 16 (12 percent) with sofosbuvir-based regimen. These treatments showed a sustained virologic response (SVR) rate of 92 percent (n=80), 100 percent (n=29) and 93.8 percent (n=15), respectively.

The SVR rate achieved was 94 percent against HCV genotype 1 (GT-1) and 100 percent against GT-2 to GT-4. The overall SVR rate was 94 percent across regimens: 93 percent in treatment-naïve patients, 96 percent in treatment-experienced patients, 93 percent in noncirrhotic patients and 94 percent in compensated cirrhotic patients.

These results were similar to those reported in pivotal trials for DAAs, according to the authors.

In this study, a clinical pharmacist-managed HCV treatment clinic in treating HCV-infected veterans with DAAs was established under a collaborative practice agreement with infectious disease physicians. Participating veterans were treated between 1 November 2014 and 30 November 2015.

To evaluate SVR after 12 weeks of treatment, the clinical pharmacist specialist engaged in the following activities: pretreatment screening, drug selection, patient education, medication counselling, drug therapy monitoring, drug utilization review, addressing issues on drug adherence, and routine and post-treatment follow-up of patients.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
Pearl Toh, Yesterday
Getting just under one extra hour of sleep per night can go a long way for the health of college students, who are often sleep-deprived, a study suggests.
29 Nov 2019
Saxagliptin 5 mg, dapagliflozin 10 mg FC tab
Roshini Claire Anthony, 5 days ago

The CA125* test could be useful at detecting ovarian cancer and various other cancers in the primary care setting, particularly for women aged >50 years, according to a study presented at the recent NCRI** Cancer Conference held in Glasgow, Scotland, UK.